Founded in 1985, Al Noor Hospital provides a complete continuum of healthcare and has places itself among the Leading private hospital services provider in Abu Dhabi. Relocation of Al Noor Hospital to Khalifa Street in 1999, Al Noor Khalifa Branch was launched in the year 2001.

In 2006, Al Noor Hospital was established in Al Ain followed by the inauguration of its unique, purpose-built hospital at Airport Road in 2008. The hospital soon evolved into a state-of-the-art healthcare provider, employing experienced medical professionals and the latest facilities. It has since achieved remarkable progress in the healthcare industry and has recently expanded to Abu Dhabi’s Western region, opening specialized clinics in Madinat Zayed, Mirfa and Mussafah, offering medical services as well as emergency referrals to its Abu Dhabi branches.

Al Noor has achieved phenomenal success in path-breaking procedures and has placed itself among the top healthcare institutions in the country. The hospital is affiliated with United Kingdom’s National Health Service and the Health Authority Abu Dhabi in addition to a number of International Health Institutions. Equipped with the latest and most advanced medical equipment the Hospital remains an inventor, always keen to introduce the latest diagnostic and treatment techniques. In April 2000 Al Noor was bestowed the prestigious ISO 2002 Certificate, the first private hospital in Abu Dhabi to achieve this award. In the year 2002 Al Noor won the International Award for Best Performance and has continued to succeed by achieving the Sheikh Khalifa Excellence awards in 2003, 2005 and 2007. The JCIA Accreditation has recently been awarded to Al Noor Hospital Al Ain City, Al Noor Hospital Khalifa Street and Al Noor Hospital Airport Road, Abu Dhabi. In 2009, Al Noor was presented with the acclaimed Sheikh Khalifa Excellence Award, Gold Category for its contribution to healthcare.

Going beyond healthcare to promote healthy living, Al Noor takes a profound interest in creating awareness about health issues in the region, including diabetes and obesity. Al Noor’s number one priority is to serve the society with the best healthcare services and is committed to maintain its position as one of the finest providers of healthcare in the private sector.


Al Noor mainly operates in Abu Dhabi, the largest emirate in the United Arab Emirates (UAE). As the sixth largest oil producer in OPEC benefiting from approximately 10 per cent of the world’s oil reserves, the UAE had a GDP of U.S. $339 billion in 2011, giving it one of the highest per capita GDPs (U.S. $50,390) in the world. Within the UAE, Abu Dhabi accounted for approximately 65 per cent of GDP in 2011, and contains 94 per cent of the UAE’s proven oil reserves. Abu Dhabi is in the process of diversifying its economy away from oil revenues.

The Healthcare sector is one of the fastest growing sectors in the UAE and it is expected to continue to grow as it benefits from this dynamic economic environment. The trends in the sector include:
A population that is growing and rapidly ageing: according to Global Insight, the population of the UAE is projected to increase by a CAGR of 1.7 per cent from 2010 to 2030, while the population over 65 years of age is projected to increase by CAGR of 9.2 per cent over that same period.
An increasing incidence of lifestyle-related medical conditions: lifestyle diseases and conditions such as diabetes, obesity, cancer and neuropsychiatric conditions tend to occur more frequently in wealthier countries such as the UAE. In particular, with respect to diabetes and obesity, in 2011, the UAE was in the top 10 countries in terms of the percentage of its population that was defined as obese (30.4 per cent), and in the top five countries in terms of the percentage of population with diabetes (18.9 per cent), according to the International Diabetes Foundation Report (5th Edition, 2012 Update).
Service gaps in the current healthcare market: The Healthcare Authority of Abu Dhabi (HAAD) has identified services for which the current supply does not meet demand in the Emirate. These include OBGYN, paediatrics, neonatology, cardiology, oncology, intensive and critical care medicine, emergency medicine and psychiatry.
Growth in the privately insured population outside of the Emirate of Abu Dhabi: other Emirates, such as Dubai and Sharjah, have announced plans to implement healthcare reforms, such as mandatory health insurance, which has led to higher per capita medical claims in the Emirate of Abu Dhabi since its introduction in 2007 (with substantial increases in expenditure on medical care in the years following its implementation).

In 2007, the Abu Dhabi Government established HAAD to regulate the quality and affordability of healthcare services in the Emirate. Among other initiatives, HAAD is focused on increasing transparency, by publishing industry-wide KPIs to provide patients with an objective source of information for use in choosing a healthcare provider. HAAD, in its 2011 report, ranked Al Noor at the forefront of services providers in terms of our quality of care and patient satisfaction.




http://www.alnoorhospital.com/

6 Oct Investec 1,030.00 Buy

Statement re Possible Offer
RNS
RNS Number : 8442B
Al Noor Hospitals Group PLC
09 October 2015



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION



THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE



FOR IMMEDIATE RELEASE

October 9th, 2015



The Board of Al Noor Hospitals Group Plc (the "Company") notes the recent media speculation in relation to the Company and confirms that it has received an approach from NMC Health Plc ("NMC") regarding a possible offer.



In accordance with Rule 2.6(a) of the Code, NMC is required, by not later than 5.00 p.m. on November 6th, 2015, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel in accordance with Rule 2.6(c) of the Code.

Recommended combination of Al Noor & Mediclinic
RNS
RNS Number : 1943C
Al Noor Hospitals Group PLC
14 October 2015



Al Noor Hospitals Group Plc
(Incorporated in England and Wales)
Company Number 8338604
Share Code: ANH
ISIN: GB00B8HX8Z88

Mediclinic International Limited
(Incorporated in the Republic of South Africa)
Registration number 1983/010725/06
Share Code: MDC
ISIN: ZAE000074142

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THE FOLLOWING ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO AL NOOR SHARES EXCEPT ON THE BASIS OF THE INFORMATION IN THE AL NOOR CIRCULAR AND PROSPECTUSES, AND THE MEDICLINIC CIRCULAR, THAT ARE PROPOSED TO BE PUBLISHED IN DUE COURSE.

14 October 2015

RECOMMENDED COMBINATION OF

AL NOOR HOSPITALS GROUP PLC
("Al Noor")

and

MEDICLINIC INTERNATIONAL LIMITED
("Mediclinic")

Further to the announcements made by Al Noor and Mediclinic on 5 October 2015 and 6 October 2015, respectively, in relation to their discussions regarding a possible combination of the two companies, the board of Al Noor and the independent board of Mediclinic are pleased to announce that they have reached agreement on the terms of a recommended combination of their respective businesses (the "Combination").

KEY HIGHLIGHTS

● Creation of a leading international private healthcare group with deep operational expertise and a well-balanced geographic profile in Southern Africa, Switzerland and the United Arab Emirates ("UAE"), as well as exposure to the UK market through a minority stake in Spire Healthcare Group plc.

● Al Noor, as enlarged by the acquisition of Mediclinic (the "Enlarged Group"), will on a revenue basis be the third largest private healthcare provider in South Africa, the largest in the UAE and the largest private medical network in Switzerland. The Enlarged Group had pro-forma revenue of USD4 billion for the fiscal period 2014/15, comprising 46% from Switzerland, 31% from South Africa and 23% from the UAE.[1]

● The Enlarged Group will operate 73 hospitals with around 10,200 beds and 35 clinics, and will have nearly 32,000 employees.

● The Combination is to be implemented by:


o
Al Noor acquiring Mediclinic pursuant to a South African scheme of arrangement, under which Mediclinic shareholders will receive 0.62500 new Al Noor shares for each Mediclinic share held[2] as well as the Mediclinic interim dividend expected to be paid in December 2015; and


o
Al Noor shareholders:

§
receiving a special dividend of GBP3.28 per Al Noor share; and

§
having the opportunity to tender their shares to Al Noor for cancellation for a cash payment of GBP8.32 per Al Noor share (subject to scale back if more than 74,069,109 Al Noor Shares are tendered).





·
An existing Al Noor shareholder that tenders its shares (and assuming no scale-back under the tender offer) will receive cash of GBP11.60 per Al Noor share, which represents a premium of approximately 39% to the closing price of GBP8.35 per Al Noor share on 1 October 2015.[3]

·
The Combination will result in Mediclinic shareholders owning 84% to 93% of the Enlarged Group, depending on take-up by existing Al Noor shareholders under the tender offer and before the subscription by Remgro for new Al Noor shares (described below) to part-fund the tender offer.

·
The cash payments to existing Al Noor shareholders in respect of the special dividend and tender offer will be partly funded through (i) a subscription by Remgro Limited or its wholly-owned subsidiary for 72,115,384 new Al Noor shares at a fixed price of GBP8.32 per share, to raise proceeds of GBP600 million; and (ii) a loan facility of up to GBP400 million.






·
Mediclinic expects the Combination to be earnings neutral to Mediclinic shareholders in the first full year of consolidation and accretive thereafter.[4]

· On completion, Al Noor will be renamed "Mediclinic International plc" and the Enlarged Group will have a premium listing on the Main Market of the London Stock Exchange, as well as an inward secondary listing on the Main Board of the Johannesburg Stock Exchange and, possibly, on the Namibian Stock Exchange.





·
The board of the Enlarged Group will comprise a majority of independent non-executive directors. Two directors from the board of Al Noor, Ian Tyler and Seamus Keating, will be on the board of the Enlarged Group, which will also include existing directors of Mediclinic. The Chairman will be Edwin Hertzog (currently Chairman of Mediclinic) and the Senior Independent Director will be Ian Tyler (currently Chairman of Al Noor). The CEO of the Enlarged Group will be Danie Meintjes and the CFO will be Craig Tingle.

·
Mediclinic and Al Noor have obtained irrevocable undertakings from Sheikh Mohammed Bin Butti Al Hamed and Dr Kassem Alom (as shareholders of Al Noor), to vote in favour of the resolutions required to approve and implement the Combination (including the special dividend and the tender offer). Dr Kassem Alom is also a non-executive director of Al Noor. These irrevocable undertakings cover 34.3% of Al Noor's outstanding shares as at 13 October 2015. Irrevocable undertakings have also been obtained from the directors of Mediclinic who hold Mediclinic shares, and from Remgro, to vote in favour of the resolutions required to approve and implement the Combination. These irrevocable undertakings cover 42.6% of Mediclinic's outstanding shares as at 13 October 2015. These irrevocable undertakings remain binding if a competing proposal is made to either Al Noor or Mediclinic, but cease to be binding from the date on which the Combination lapses or is withdrawn in accordance with its terms.


Commenting on the proposed Combination, Danie Meintjes, CEO of Mediclinic, said:

"We are delighted to announce a combination of Mediclinic and Al Noor to create the leader in the important growth market of the UAE. Al Noor's strong brand and delivery of high-quality patient care aligns closely with Mediclinic's premium service offering, and its success is reflected in its strong financial track record of sustained growth. The combined business represents a unique platform from which to pursue numerous expansion opportunities in the high-growth UAE and wider Middle East healthcare market, reinforcing our commitment to providing investment to drive the delivery of world class healthcare services in the region. The Combination also further diversifies Mediclinic's geographic profile internationally, gives us additional exposure to USD-based high-growth earnings, and generates incremental financial and trading benefits through a listing on the LSE."


Commenting on the proposed Combination, Ronald Lavater, CEO of Al Noor, said:

"The companies make a compelling strategic fit, in terms of complementary geographies and a shared commitment to providing outstanding patient care. As one of the world's largest acute hospital operators outside the United States, this will be a platform for further growth and delivery of world class service, benefiting all our stakeholders, from the communities we serve, to our talented employees and our investors. In the key growth market of the UAE, the combined company will be the largest private healthcare provider in the country (by revenue), giving patients access points in most major urban centres. We have an excellent opportunity to leverage this strength to expand coverage and service delivery, responding to burgeoning demand for world class healthcare."


The Combination will be subject to the conditions set out in this announcement (including its appendices) and to the full terms and conditions that will be set out in the shareholder circulars to be published by Al Noor and Mediclinic, respectively, in due course. It is currently expected that, subject to the satisfaction or waiver of the conditions, the shareholder meetings will be held in December 2015 and the Combination will complete during the first quarter of 2016.

These highlights should be read in conjunction with, and are subject to, the full text of this announcement (including its appendices). A copy of this announcement will be available, subject to certain restrictions relating to persons resident in restricted jurisdictions, at www.alnoorhospital.com and www.mediclinic.com. The content of these websites is not incorporated into and does not form part of this announcement.

Analyst and investor

DC - i trust you actually hold these
confess i looked at them some time ago, and for no particular reason, i didn't buy
this has done even better than DOM, and that is no mean achievement :-)

Yes @ 840p (Feb 2014)

Company News

Al Noor and Mediclinic boards agree to merger terms

Wed, 14 October 2015

(ShareCast News) - The boards of Al Noor and Mediclinic have reached an agreement on the terms of a possible merger.
Under the proposed deal announced on Wednesday, Al Noor will acquire Mediclinic, with shareholders receiving 0.625 new shares for each Mediclinic share held.

Al Noor shareholders will also receive a special dividend of £3.28 per share and the opportunity to tender their shares for a cash payment

The proposed deal will result in Mediclinic shareholders owning 84% to 93% of the enlarged group.

The groups said the merger will create a "leading international private healthcare group with deep operational expertise and a well-balanced geographic profile in Southern Africa, Switzerland and the United Arab Emirates".

It will also have exposure to the UK market through a minority stake in Spire Healthcare Group.

Al Noor chief executive Ronald Lavater said the companies make a compelling strategic fit in terms of complementary geographies and a shared commitment to providing outstanding patient care.

"As one of the world's largest acute hospital operators outside the United States, this will be a platform for further growth and delivery of world class service, benefiting all our stakeholders, from the communities we serve, to our talented employees and our investors," he said.

"We have an excellent opportunity to leverage this strength to expand coverage and service delivery, responding to burgeoning demand for world class healthcare."

The merger is expected to be completed in the first quarter of 2016, with shareholder meetings to be held in December 2015.

However NMC Health, another company interested in merging with Al Noor, isn't giving up so easily.

It released a statement after the announcement saying it confirms its belief in the competitiveness of the possible initial offer.

"The combination of NMC and Al Noor has the strongest strategic and financial rationale for all stakeholders.

"We reiterate our commitment to this opportunity despite the lack of meaningful engagement from the board of Al Noor."

Investec noted that if the Al Noor and Mediclinic merger goes ahead, NMC won't be affected by it.

"The company has a greater number of private beds and has been creating speciality niches in much needed areas such as IVF and long-term care.

"NMC is also ahead of Al Noor and MDC in preparing for the roll out of mandatory health insurance in Sharjah."

At 1240 BST, Al Noor shares were up 184.5p to 1,179p.

Statement re: VPS Healthcare
RNS
RNS Number : 7820C
Al Noor Hospitals Group PLC
20 October 2015



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION



THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE



FOR IMMEDIATE RELEASE

20 October 2015





The Board of Al Noor Hospitals Group Plc (the "Company") notes the comments made to the media by CEO Ronald Lavater, and confirms it has received a highly preliminary indication of interest from VPS Healthcare ("VPS"), however no formal proposal or indicative terms were received.



In accordance with Rule 2.6(a) of the Code, VPS is required, by not later than 5.00 p.m. on November 17th, 2015, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel in accordance with Rule 2.6(c) of the Code.

Company News

NMC Health abandons bid for Al Noor Hospitals

Mon, 16 November 2015


(ShareCast News) - NMC Health has abandoned its bid for Al Noor Hospitals, meaning South Africa's Mediclinic International looks set to clinch a deal with the Abu Dhabi-based healthcare operator.
Al Noor confirmed in early October that it had received an approach from NMC regarding a possible offer.

NMC said on Monday: "After a thorough assessment of the opportunity, NMC has concluded that the potential transaction would not deliver sufficient returns or shareholder value in line with its stated policy, and accordingly NMC now confirms that it does not intend to make an offer for Al Noor."

Last month, the boards of Al Noor and Mediclinic reached an agreement on the terms of a possible merger.

Under the proposed deal announced, Al Noor will acquire Mediclinic, with shareholders receiving 0.625 new shares for each Mediclinic share held.

The proposed deal will result in Mediclinic shareholders owning 84% to 93% of the enlarged group.

The groups said the merger will create a "leading international private healthcare group with deep operational expertise and a well-balanced geographic profile in Southern Africa, Switzerland and the United Arab Emirates".

At 1450 GMT, NMC Health shares were up 1.9% to 773.50p, while Al Noor was flat at 1,158p

Company News

Mediclinic set to clinch deal with Al Noor as VPS drops out

Mon, 30 November 2015


(ShareCast News) - South Africa's Mediclinic looks set to clinch its deal with Emirates-based healthcare provider Al Noor Hospitals after Abu Dhabi-based VPS Healthcare said on Monday that it does not intend to make an offer for the company.
On 20 October, Al Noor announced that it had received a preliminary indication of interest from VPS.

However, after a thorough assessment of the opportunity, VPS has concluded the potential transaction would not be in the best interests of the company and accordingly confirmed that it does not intend to make an offer for Al Noor.

Al Noor has already agreed a £1.4bn deal with Mediclinic, which now looks to be winning the race with both NMC Health and VPS no longer interested.

NMC said earlier this month that it had abandoned its bid for Al Noor as the transaction "would not deliver sufficient returns or shareholder value".

Results of meeting

Update on competition process and revised timetable

First Reduction Of Capital Effective
RNS
RNS Number : 7169M
Al Noor Hospitals Group PLC
22 January 2016

Al Noor Hospitals Group Plc
(Incorporated in England and Wales)
Company Number 8338604
Share Code: ANH
ISIN: GB00B8HX8Z88

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.



22 January 2016

FIRST REDUCTION OF CAPITAL EFFECTIVE

The Board of Al Noor Hospitals Group Plc ("Al Noor") is pleased to announce that, on 21 January 2016, the High Court of Justice (the "Court") made an order confirming the reduction of Al Noor's share capital and cancellation of Al Noor's share premium account (the "First Reduction").

The First Reduction became effective on 21 January 2016 upon the Court's order being registered by the Registrar of Companies. A hearing of the Court is scheduled for 16 February 2016 to confirm a further reduction of Al Noor's share capital and share premium account (the "Second Reduction"), and the Second Reduction is expected to become effective by 17 February 2016.

The First Reduction and the Second Reduction will enable Al Noor to pay the special dividend and effect the tender offer to shareholders in connection with the combination with Mediclinic International Limited (the "Combination"). A revised expected timetable of events in relation to the Combination is set out in the announcement of Al Noor dated 19 January 2016.

A copy of this announcement will be available, subject to certain restrictions relating to persons resident in restricted jurisdictions, at www.alnoorhospital.com. The content of this website is not incorporated into and does not form part of this announcement.

Combination unconditional

Ex dividend today - 11 Feb 2016 Al Noor Hospitals Group PLC (328 P)

really????? ..... i was about to write that that doesn't explain a drop of £3.00+

Al Noor Hospitals Group PLC (LON:ANH) declared a dividend on Friday, October 14th, Stockholders of record on Thursday, February 11th will be given a dividend of GBX 328 ($4.72) per share on Wednesday, March 2nd. This represents a dividend yield of 28.65%. The ex-dividend date of this dividend is Thursday, February 11th

The drop today was very close to the dividend.

Now Mediclinic International Plc